Location History:
- Odense M, DK (2013)
- Copenhagen, DK (2008 - 2022)
Company Filing History:
2 out of 3 
2 out of 2 
1 out of 1,187 
Years Active: 2008-2022
Title: Trond Ulven: A Pioneer in Antidiabetic Innovations
Introduction
Trond Ulven is an innovative inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmacology with his work resulting in six patents. His research focuses primarily on compounds that regulate insulin levels and combat metabolic diseases including diabetes.
Latest Patents
Two of Trond Ulven's latest patents showcase his dedication to improving health outcomes. The first patent involves "Tetrahydro-benzo[d]azepine derivatives as GPR120 modulators," which details novel compounds capable of modulating the G-protein-coupled receptor GPR120. These compounds are crucial for controlling insulin levels in vivo and have potential applications for treating diabetes, inflammation, obesity, and other metabolic diseases.
The second patent, titled "Antidiabetic enolic glucoside of phenylpyruvic acid," presents an innovative glucoside that functions as a medicament for lowering blood glucose levels in obese and pre-diabetic mammals. The compounds significantly help manage and normalize blood sugar levels while enhancing glucose uptake by cells, thereby improving glucose tolerance.
Career Highlights
Trond Ulven has worked with reputable organizations, including Zadec Aps and Caldan Therapeutics Limited. His roles within these companies have allowed him to lead and contribute to research initiatives aimed at discovering new therapeutic solutions.
Collaborations
Throughout his career, Trond has collaborated with talented professionals such as Elizabeth Joubert and Stephen J Fey. These collaborations have facilitated knowledge exchange and idea generation, further enriching his contributions to the field.
Conclusion
With a focus on innovative solutions for diabetes and metabolic disorders, Trond Ulven continues to make strides in pharmaceuticals through his inventive patents. His research not only advances medical science but also offers hope for countless individuals managing chronic conditions.